Gavin T. Malenfant - Oct 26, 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Operating Officer, Director
Signature
/s/ Max A. Milbury, Attorney-in-Fact for Gavin T. Malenfant
Stock symbol
PMN
Transactions as of
Oct 26, 2023
Transactions value $
$0
Form type
4
Date filed
10/30/2023, 07:51 PM
Previous filing
Aug 25, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +12.5K $0.00 12.5K Oct 26, 2023 Common Stock 12.5K $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months.